Supplemental Table 1&2
Published: 28 June 2020| Version 1 | DOI: 10.17632/xpdv4dt79b.1
Contributor:
Cristina Muniesa Montserrat
Description
Table 1. Summary of patients with PCFCL treated with systemic rituximab. Table 2. Summary of patients with PCMZL treated with systemic rituximab.